Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment

BACKGROUND: Schizophrenia patients are a population at particular risk of poor outcomes in COVID-19 infection. They have multiple comorbidities that have been identified as risk factors for severe COVID-19: diabetes, hypertension, chronic obstructive respiratory disease, and end-stage renal disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Moga, Silvia, Teodorescu, Andreea, Ifteni, Petru, Gavris, Claudia, Petric, Paula-Simina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495225/
https://www.ncbi.nlm.nih.gov/pubmed/34629871
http://dx.doi.org/10.2147/NDT.S325062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495225/
https://www.ncbi.nlm.nih.gov/pubmed/34629871
http://dx.doi.org/10.2147/NDT.S325062

Ejemplares similares